A Study of the Effect of a Nurse Navigator Program on High Risk Patients
Not Applicable
Not yet recruiting
- Conditions
- Arthroplasty, Replacement, KneeHeart FailureArthroplasty, Replacement, HipPulmonary Disease, Chronic ObstructivePatient ReadmissionBody Mass IndexAlcoholismRenal Insufficiency
- Registration Number
- NCT05592847
- Lead Sponsor
- Mayo Clinic
- Brief Summary
The purpose of this study is to examine if educational intervention in high risk patients can lead to decreased hospital readmissions when compared to patients who are not in the intervention program. Additionally, to determine patient satisfaction with the educational program.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
- Require total or partial hip or knee replacement and have one or more of the following diagnosis: Heart Failure (HF); Chronic obstructive pulmonary disease (COPD); Dialysis; Alcohol Abuse; Low BMI.
Exclusion Criteria
- Decrease cognitive capacity to consent to the study.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Readmission rates One year
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the impact of nurse navigators on COPD patient outcomes?
How does the Nurse Navigator Program compare to standard care in reducing 30-day readmissions for CHF patients with elevated BMI?
Are there specific biomarkers associated with high-risk patients benefiting most from nurse-led interventions in dialysis-dependent renal insufficiency?
What adverse events are commonly reported in nurse-coordinated care models for patients with a history of alcohol abuse and comorbid conditions?
What combination therapies or pharmaceutical interventions are being explored alongside nurse navigators for knee arthroplasty patients with multiple risk factors?
Trial Locations
- Locations (1)
Mayo Clinic Florida
🇺🇸Jacksonville, Florida, United States
Mayo Clinic Florida🇺🇸Jacksonville, Florida, United States